Literature DB >> 24829471

Clinical research strategies for fructose metabolism.

Maren R Laughlin1, John P Bantle2, Peter J Havel3, Elizabeth Parks4, David M Klurfeld5, Karen Teff6, Padma Maruvada6.   

Abstract

Fructose and simple sugars are a substantial part of the western diet, and their influence on human health remains controversial. Clinical studies in fructose nutrition have proven very difficult to conduct and interpret. NIH and USDA sponsored a workshop on 13-14 November 2012, "Research Strategies for Fructose Metabolism," to identify important scientific questions and parameters to be considered while designing clinical studies. Research is needed to ascertain whether there is an obesogenic role for fructose-containing sugars via effects on eating behavior and energy balance and whether there is a dose threshold beyond which these sugars promote progression toward diabetes and liver and cardiovascular disease, especially in susceptible populations. Studies tend to fall into 2 categories, and design criteria for each are described. Mechanistic studies are meant to validate observations made in animals or to elucidate the pathways of fructose metabolism in humans. These highly controlled studies often compare the pure monosaccharides glucose and fructose. Other studies are focused on clinically significant disease outcomes or health behaviors attributable to amounts of fructose-containing sugars typically found in the American diet. These are designed to test hypotheses generated from short-term mechanistic or epidemiologic studies and provide data for health policy. Discussion brought out the opinion that, although many mechanistic questions concerning the metabolism of monosaccharide sugars in humans remain to be addressed experimentally in small highly controlled studies, health outcomes research meant to inform health policy should use large, long-term studies using combinations of sugars found in the typical American diet rather than pure fructose or glucose.
© 2014 American Society for Nutrition.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24829471      PMCID: PMC4013177          DOI: 10.3945/an.113.005249

Source DB:  PubMed          Journal:  Adv Nutr        ISSN: 2161-8313            Impact factor:   8.701


  73 in total

1.  Intracerebroventricular injection of fructose stimulates feeding in rats.

Authors:  Cheryl C Miller; Roy J Martin; Michelle L Whitney; Gaylen L Edwards
Journal:  Nutr Neurosci       Date:  2002-10       Impact factor: 4.994

Review 2.  Metabolic effects of fructose and the worldwide increase in obesity.

Authors:  Luc Tappy; Kim-Anne Lê
Journal:  Physiol Rev       Date:  2010-01       Impact factor: 37.312

3.  Glucose and fructose feeding lead to alterations in structure and function of very low density lipoproteins.

Authors:  L Verschoor; Y D Chen; E P Reaven; G M Reaven
Journal:  Horm Metab Res       Date:  1985-06       Impact factor: 2.936

4.  The carbon isotope ratio of alanine in red blood cells is a new candidate biomarker of sugar-sweetened beverage intake.

Authors:  Kyungcheol Choy; Sarah H Nash; Alan R Kristal; Scarlett Hopkins; Bert B Boyer; Diane M O'Brien
Journal:  J Nutr       Date:  2013-04-24       Impact factor: 4.798

5.  Hepatic metabolism during constant infusion of fructose; comparative studies with 31P-magnetic resonance spectroscopy in man and rats.

Authors:  S Masson; O Henriksen; A Stengaard; C Thomsen; B Quistorff
Journal:  Biochim Biophys Acta       Date:  1994-03-02

Review 6.  Use and abuse of hydrogen breath tests.

Authors:  M Simrén; P-O Stotzer
Journal:  Gut       Date:  2006-03       Impact factor: 23.059

Review 7.  Fructose malabsorption and intolerance: effects of fructose with and without simultaneous glucose ingestion.

Authors:  Marie E Latulippe; Suzanne M Skoog
Journal:  Crit Rev Food Sci Nutr       Date:  2011-08       Impact factor: 11.176

8.  Consumption of fructose- but not glucose-sweetened beverages for 10 weeks increases circulating concentrations of uric acid, retinol binding protein-4, and gamma-glutamyl transferase activity in overweight/obese humans.

Authors:  Chad L Cox; Kimber L Stanhope; Jean Marc Schwarz; James L Graham; Bonnie Hatcher; Steven C Griffen; Andrew A Bremer; Lars Berglund; John P McGahan; Nancy L Keim; Peter J Havel
Journal:  Nutr Metab (Lond)       Date:  2012-07-24       Impact factor: 4.169

Review 9.  The effects of fructose intake on serum uric acid vary among controlled dietary trials.

Authors:  D David Wang; John L Sievenpiper; Russell J de Souza; Laura Chiavaroli; Vanessa Ha; Adrian I Cozma; Arash Mirrahimi; Matthew E Yu; Amanda J Carleton; Marco Di Buono; Alexandra L Jenkins; Lawrence A Leiter; Thomas M S Wolever; Joseph Beyene; Cyril W C Kendall; David J A Jenkins
Journal:  J Nutr       Date:  2012-03-28       Impact factor: 4.798

10.  Endogenous fructose production and metabolism in the liver contributes to the development of metabolic syndrome.

Authors:  Miguel A Lanaspa; Takuji Ishimoto; Nanxing Li; Christina Cicerchi; David J Orlicky; Philip Ruzycki; Philip Ruzicky; Christopher Rivard; Shinichiro Inaba; Carlos A Roncal-Jimenez; Elise S Bales; Christine P Diggle; Aruna Asipu; J Mark Petrash; Tomoki Kosugi; Shoichi Maruyama; Laura G Sanchez-Lozada; James L McManaman; David T Bonthron; Yuri Y Sautin; Richard J Johnson
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

View more
  4 in total

1.  Carbohydrates.

Authors:  Joanne Slavin; Justin Carlson
Journal:  Adv Nutr       Date:  2014-11-14       Impact factor: 8.701

2.  Fructose decreases physical activity and increases body fat without affecting hippocampal neurogenesis and learning relative to an isocaloric glucose diet.

Authors:  Catarina Rendeiro; Ashley M Masnik; Jonathan G Mun; Kristy Du; Diana Clark; Ryan N Dilger; Anna C Dilger; Justin S Rhodes
Journal:  Sci Rep       Date:  2015-04-20       Impact factor: 4.379

Review 3.  The role of dietary sugars and de novo lipogenesis in non-alcoholic fatty liver disease.

Authors:  J Bernadette Moore; Pippa J Gunn; Barbara A Fielding
Journal:  Nutrients       Date:  2014-12-10       Impact factor: 5.717

4.  Fructose Containing Sugars at Normal Levels of Consumption Do Not Effect Adversely Components of the Metabolic Syndrome and Risk Factors for Cardiovascular Disease.

Authors:  Theodore J Angelopoulos; Joshua Lowndes; Stephanie Sinnett; James M Rippe
Journal:  Nutrients       Date:  2016-03-23       Impact factor: 5.717

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.